Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20050038087 | Derivatives of heterocycles with 5 members, their preparation and their use as medicaments The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionall... | 02/17/2005 |
| 20050038094 | Pesticidal formulations A concentrated pesticidal solution is provided which comprises one or more water-insoluble pesticides (usually 0.5-50% w/v) and lignin (suitably in the weight ratio of 1:10 to 1:1 of lignin to pesticide) dissolved in a water miscible, polar solvent, preferably N-methyl ... | 02/17/2005 |
| 20050038019 | Hydroxy substituted amides for the treatment of alzheimer's disease The present invention is a method of treating Alzheimer's disease, and other diseases, and/or inhibiting beta-secretase enzyme, and/or inhibiting deposition of A beta peptide in a mammal, by use of known compounds of Formula (I), wherein, A, R, J, and n are as defined ... | 02/17/2005 |
| 20050032788 | Method for treating fibrotic diseases or other indications utilizing thiazole, oxazole and imidazole compounds Provided is a method of treating or ameliorating a number of indications in an animal, including a human, comprising administering an effective amount of a compound of the formula I or IA, wherein J is oxygen, sulfur, or N—Rd. ... | 02/10/2005 |
| 20050032851 | Process for preparing prodrugs of benzenesulfonamide-containing COX-2 inhibitors Prodrugs of COX-2 inhibitors are described as being useful in treating inflammation and inflammation-related disorders. ... | 02/10/2005 |
| 20050032787 | Pheny (alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity Formula (I) compounds are described: Where the groups are as defined here below, and their use as medinies, particularly as serum glucose and serum lipid lowering agents. Said medicines are useful for the prophylaxis and treatment of diabetes, particularly type 2, and ... | 02/10/2005 |
| 20050026982 | Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient The invention consists of a composition that an alpha, omega-n-alkanedicarboxylic acid and an imidazole derivative with general formula whereby R is a hydrogen atom or an alkyl group, A is a saturated chain of an aliphatic hydrocarbon group, X is a hydrogen atom or ... | 02/03/2005 |
| 20050026929 | Novel phenyl derivatives as inducers of apoptosis The present invention related to certain phenyl derivatives that are activators of caspases and inducers of apoptosis, pharmaceutical composition comprising these compounds and method of treating cancer utilizing these compounds. ... | 02/03/2005 |
| 20050014805 | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity This invention relates to novel heterocyclic compounds, compositions, and methods for treating or preventing obesity and obesity-related diseases. ... | 01/20/2005 |
| 20050009816 | Potassium channel modulators This invention relates to novel compounds useful as potassium channel modulators. More specifically the invention provides chemical compounds useful as modulators of SKCa and/or IKCa channels. ... | 01/13/2005 |
| 20050004115 | Compounds for the treatment of metabolic disorders Compounds useful for the treatment of various metabolic disorders, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis, are disclosed. ... | 01/06/2005 |
| 20050004112 | C-fms kinase inhibitors The invention is directed to compounds of Formulae I, II and III: wherein A, R1, R2, R3, R4, X, Y and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salt... | 01/06/2005 |
